Industry Research Reports
Home > Reports > Chemical & Material > Neomycin Sulfate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Neomycin Sulfate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-02-14
Pages: 126 Pages
Report ld: 3824100
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Neomycin Sulfate API Market Size(US$)
CAGR 2025-2031
6.5%
Market Size,2031
USD 283
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 194 million
Market Forecast in 2031(Value)
US$ 283 million
CAGR
6.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Neomycin Sulfate API was estimated to be worth US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
The API industry is an important part of the pharmaceutical industry and involves the primary production stage of drugs. In this industry, chemical, biological or other technological methods are used to synthesize, extract or manufacture the active ingredients of drugs, which are called active ingredients. APIs are the core components of medicines, and their quality and purity are critical to the safety and effectiveness of medicines. The API industry includes many aspects such as drug research and development, production, supervision and quality control. It is one of the key industries supporting the medical care system and has an important impact on human health. The development of this industry is affected by various factors such as technological progress, regulatory changes and market demand, and is highly complex and competitive.
This report aims to provide a comprehensive presentation of the global market for Neomycin Sulfate API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Neomycin Sulfate API by region & country, by Type, and by Application.
The Neomycin Sulfate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neomycin Sulfate API.
MARKET SEGMENTATION
By Company
- Yichang Three Gorges Pharmaceutical
- Shandong Saito Biotechnology
- Xinyu Pharmaceutical
- Renfu Medicine
- Manus Aktteva Biopharma
- DKSH
- Fagron Industry
- Caesar & Loretz GmbH
- Syndesmos
- B Joshi Agrochem Pharma
- Crystal Pharma
- Sichuan Long March Pharmaceuticals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Veterinary Use
- Human Use
Segment by Application
- Biopharmaceutical
- Research
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Neomycin Sulfate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Neomycin Sulfate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Neomycin Sulfate API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Neomycin Sulfate API Product Introduction
1.2 Global Neomycin Sulfate API Market Size Forecast
1.2.1 Global Neomycin Sulfate API Sales Value (2020-2031)
1.2.2 Global Neomycin Sulfate API Sales Volume (2020-2031)
1.2.3 Global Neomycin Sulfate API Sales Price (2020-2031)
1.3 Neomycin Sulfate API Market Trends & Drivers
1.3.1 Neomycin Sulfate API Industry Trends
1.3.2 Neomycin Sulfate API Market Drivers & Opportunity
1.3.3 Neomycin Sulfate API Market Challenges
1.3.4 Neomycin Sulfate API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Neomycin Sulfate API Players Revenue Ranking (2024)
2.2 Global Neomycin Sulfate API Revenue by Company (2020-2025)
2.3 Global Neomycin Sulfate API Players Sales Volume Ranking (2024)
2.4 Global Neomycin Sulfate API Sales Volume by Company Players (2020-2025)
2.5 Global Neomycin Sulfate API Average Price by Company (2020-2025)
2.6 Key Manufacturers Neomycin Sulfate API Manufacturing Base and Headquarters
2.7 Key Manufacturers Neomycin Sulfate API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Neomycin Sulfate API
2.9 Neomycin Sulfate API Market Competitive Analysis
2.9.1 Neomycin Sulfate API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Neomycin Sulfate API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neomycin Sulfate API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Veterinary Use
3.1.2 Human Use
3.2 Global Neomycin Sulfate API Sales Value by Type
3.2.1 Global Neomycin Sulfate API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Neomycin Sulfate API Sales Value, by Type (2020-2031)
3.2.3 Global Neomycin Sulfate API Sales Value, by Type (%) (2020-2031)
3.3 Global Neomycin Sulfate API Sales Volume by Type
3.3.1 Global Neomycin Sulfate API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Neomycin Sulfate API Sales Volume, by Type (2020-2031)
3.3.3 Global Neomycin Sulfate API Sales Volume, by Type (%) (2020-2031)
3.4 Global Neomycin Sulfate API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biopharmaceutical
4.1.2 Research
4.2 Global Neomycin Sulfate API Sales Value by Application
4.2.1 Global Neomycin Sulfate API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Neomycin Sulfate API Sales Value, by Application (2020-2031)
4.2.3 Global Neomycin Sulfate API Sales Value, by Application (%) (2020-2031)
4.3 Global Neomycin Sulfate API Sales Volume by Application
4.3.1 Global Neomycin Sulfate API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Neomycin Sulfate API Sales Volume, by Application (2020-2031)
4.3.3 Global Neomycin Sulfate API Sales Volume, by Application (%) (2020-2031)
4.4 Global Neomycin Sulfate API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Neomycin Sulfate API Sales Value by Region
5.1.1 Global Neomycin Sulfate API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Neomycin Sulfate API Sales Value by Region (2020-2025)
5.1.3 Global Neomycin Sulfate API Sales Value by Region (2026-2031)
5.1.4 Global Neomycin Sulfate API Sales Value by Region (%), (2020-2031)
5.2 Global Neomycin Sulfate API Sales Volume by Region
5.2.1 Global Neomycin Sulfate API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Neomycin Sulfate API Sales Volume by Region (2020-2025)
5.2.3 Global Neomycin Sulfate API Sales Volume by Region (2026-2031)
5.2.4 Global Neomycin Sulfate API Sales Volume by Region (%), (2020-2031)
5.3 Global Neomycin Sulfate API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Neomycin Sulfate API Sales Value, 2020-2031
5.4.2 North America Neomycin Sulfate API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Neomycin Sulfate API Sales Value, 2020-2031
5.5.2 Europe Neomycin Sulfate API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Neomycin Sulfate API Sales Value, 2020-2031
5.6.2 Asia Pacific Neomycin Sulfate API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Neomycin Sulfate API Sales Value, 2020-2031
5.7.2 South America Neomycin Sulfate API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Neomycin Sulfate API Sales Value, 2020-2031
5.8.2 Middle East & Africa Neomycin Sulfate API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Neomycin Sulfate API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Neomycin Sulfate API Sales Value
6.2.1 Key Countries/Regions Neomycin Sulfate API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Neomycin Sulfate API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Neomycin Sulfate API Sales Value, 2020-2031
6.3.2 United States Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Neomycin Sulfate API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Neomycin Sulfate API Sales Value, 2020-2031
6.4.2 Europe Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Neomycin Sulfate API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Neomycin Sulfate API Sales Value, 2020-2031
6.5.2 China Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Neomycin Sulfate API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Neomycin Sulfate API Sales Value, 2020-2031
6.6.2 Japan Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Neomycin Sulfate API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Neomycin Sulfate API Sales Value, 2020-2031
6.7.2 South Korea Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Neomycin Sulfate API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Neomycin Sulfate API Sales Value, 2020-2031
6.8.2 Southeast Asia Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Neomycin Sulfate API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Neomycin Sulfate API Sales Value, 2020-2031
6.9.2 India Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Neomycin Sulfate API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Yichang Three Gorges Pharmaceutical
7.1.1 Yichang Three Gorges Pharmaceutical Company Information
7.1.2 Yichang Three Gorges Pharmaceutical Introduction and Business Overview
7.1.3 Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Product Offerings
7.1.5 Yichang Three Gorges Pharmaceutical Recent Development
7.2 Shandong Saito Biotechnology
7.2.1 Shandong Saito Biotechnology Company Information
7.2.2 Shandong Saito Biotechnology Introduction and Business Overview
7.2.3 Shandong Saito Biotechnology Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Shandong Saito Biotechnology Neomycin Sulfate API Product Offerings
7.2.5 Shandong Saito Biotechnology Recent Development
7.3 Xinyu Pharmaceutical
7.3.1 Xinyu Pharmaceutical Company Information
7.3.2 Xinyu Pharmaceutical Introduction and Business Overview
7.3.3 Xinyu Pharmaceutical Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Xinyu Pharmaceutical Neomycin Sulfate API Product Offerings
7.3.5 Xinyu Pharmaceutical Recent Development
7.4 Renfu Medicine
7.4.1 Renfu Medicine Company Information
7.4.2 Renfu Medicine Introduction and Business Overview
7.4.3 Renfu Medicine Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Renfu Medicine Neomycin Sulfate API Product Offerings
7.4.5 Renfu Medicine Recent Development
7.5 Manus Aktteva Biopharma
7.5.1 Manus Aktteva Biopharma Company Information
7.5.2 Manus Aktteva Biopharma Introduction and Business Overview
7.5.3 Manus Aktteva Biopharma Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Manus Aktteva Biopharma Neomycin Sulfate API Product Offerings
7.5.5 Manus Aktteva Biopharma Recent Development
7.6 DKSH
7.6.1 DKSH Company Information
7.6.2 DKSH Introduction and Business Overview
7.6.3 DKSH Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 DKSH Neomycin Sulfate API Product Offerings
7.6.5 DKSH Recent Development
7.7 Fagron Industry
7.7.1 Fagron Industry Company Information
7.7.2 Fagron Industry Introduction and Business Overview
7.7.3 Fagron Industry Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Fagron Industry Neomycin Sulfate API Product Offerings
7.7.5 Fagron Industry Recent Development
7.8 Caesar & Loretz GmbH
7.8.1 Caesar & Loretz GmbH Company Information
7.8.2 Caesar & Loretz GmbH Introduction and Business Overview
7.8.3 Caesar & Loretz GmbH Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Caesar & Loretz GmbH Neomycin Sulfate API Product Offerings
7.8.5 Caesar & Loretz GmbH Recent Development
7.9 Syndesmos
7.9.1 Syndesmos Company Information
7.9.2 Syndesmos Introduction and Business Overview
7.9.3 Syndesmos Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Syndesmos Neomycin Sulfate API Product Offerings
7.9.5 Syndesmos Recent Development
7.10 B Joshi Agrochem Pharma
7.10.1 B Joshi Agrochem Pharma Company Information
7.10.2 B Joshi Agrochem Pharma Introduction and Business Overview
7.10.3 B Joshi Agrochem Pharma Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 B Joshi Agrochem Pharma Neomycin Sulfate API Product Offerings
7.10.5 B Joshi Agrochem Pharma Recent Development
7.11 Crystal Pharma
7.11.1 Crystal Pharma Company Information
7.11.2 Crystal Pharma Introduction and Business Overview
7.11.3 Crystal Pharma Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Crystal Pharma Neomycin Sulfate API Product Offerings
7.11.5 Crystal Pharma Recent Development
7.12 Sichuan Long March Pharmaceuticals
7.12.1 Sichuan Long March Pharmaceuticals Company Information
7.12.2 Sichuan Long March Pharmaceuticals Introduction and Business Overview
7.12.3 Sichuan Long March Pharmaceuticals Neomycin Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Sichuan Long March Pharmaceuticals Neomycin Sulfate API Product Offerings
7.12.5 Sichuan Long March Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Neomycin Sulfate API Industrial Chain
8.2 Neomycin Sulfate API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Neomycin Sulfate API Sales Model
8.5.2 Sales Channel
8.5.3 Neomycin Sulfate API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Neomycin Sulfate API Market Trends
Table 2. Neomycin Sulfate API Market Drivers & Opportunity
Table 3. Neomycin Sulfate API Market Challenges
Table 4. Neomycin Sulfate API Market Restraints
Table 5. Global Neomycin Sulfate API Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Neomycin Sulfate API Revenue Market Share by Company (2020-2025)
Table 7. Global Neomycin Sulfate API Sales Volume by Company (2020-2025) & (Tons)
Table 8. Global Neomycin Sulfate API Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Neomycin Sulfate API Price by Company (2020-2025) & (US$/Ton)
Table 10. Key Manufacturers Neomycin Sulfate API Manufacturing Base and Headquarters
Table 11. Key Manufacturers Neomycin Sulfate API Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Neomycin Sulfate API
Table 13. Global Neomycin Sulfate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neomycin Sulfate API as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Neomycin Sulfate API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Neomycin Sulfate API Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Neomycin Sulfate API Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Neomycin Sulfate API Sales Market Share in Value by Type (2020-2025)
Table 20. Global Neomycin Sulfate API Sales Market Share in Value by Type (2026-2031)
Table 21. Global Neomycin Sulfate API Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Neomycin Sulfate API Sales Volume by Type (2020-2025) & (Tons)
Table 23. Global Neomycin Sulfate API Sales Volume by Type (2026-2031) & (Tons)
Table 24. Global Neomycin Sulfate API Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Neomycin Sulfate API Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Neomycin Sulfate API Price by Type (2020-2025) & (US$/Ton)
Table 27. Global Neomycin Sulfate API Price by Type (2026-2031) & (US$/Ton)
Table 28. Global Neomycin Sulfate API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Neomycin Sulfate API Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Neomycin Sulfate API Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Neomycin Sulfate API Sales Market Share in Value by Application (2020-2025)
Table 32. Global Neomycin Sulfate API Sales Market Share in Value by Application (2026-2031)
Table 33. Global Neomycin Sulfate API Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
Table 34. Global Neomycin Sulfate API Sales Volume by Application (2020-2025) & (Tons)
Table 35. Global Neomycin Sulfate API Sales Volume by Application (2026-2031) & (Tons)
Table 36. Global Neomycin Sulfate API Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Neomycin Sulfate API Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Neomycin Sulfate API Price by Application (2020-2025) & (US$/Ton)
Table 39. Global Neomycin Sulfate API Price by Application (2026-2031) & (US$/Ton)
Table 40. Global Neomycin Sulfate API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Neomycin Sulfate API Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Neomycin Sulfate API Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Neomycin Sulfate API Sales Value by Region (2020-2025) & (%)
Table 44. Global Neomycin Sulfate API Sales Value by Region (2026-2031) & (%)
Table 45. Global Neomycin Sulfate API Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
Table 46. Global Neomycin Sulfate API Sales Volume by Region (2020-2025) & (Tons)
Table 47. Global Neomycin Sulfate API Sales Volume by Region (2026-2031) & (Tons)
Table 48. Global Neomycin Sulfate API Sales Volume by Region (2020-2025) & (%)
Table 49. Global Neomycin Sulfate API Sales Volume by Region (2026-2031) & (%)
Table 50. Global Neomycin Sulfate API Average Price by Region (2020-2025) & (US$/Ton)
Table 51. Global Neomycin Sulfate API Average Price by Region (2026-2031) & (US$/Ton)
Table 52. Key Countries/Regions Neomycin Sulfate API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Neomycin Sulfate API Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Neomycin Sulfate API Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Neomycin Sulfate API Sales Volume, (2020-2025) & (Tons)
Table 56. Key Countries/Regions Neomycin Sulfate API Sales Volume, (2026-2031) & (Tons)
Table 57. Yichang Three Gorges Pharmaceutical Company Information
Table 58. Yichang Three Gorges Pharmaceutical Introduction and Business Overview
Table 59. Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 60. Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Product Offerings
Table 61. Yichang Three Gorges Pharmaceutical Recent Development
Table 62. Shandong Saito Biotechnology Company Information
Table 63. Shandong Saito Biotechnology Introduction and Business Overview
Table 64. Shandong Saito Biotechnology Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 65. Shandong Saito Biotechnology Neomycin Sulfate API Product Offerings
Table 66. Shandong Saito Biotechnology Recent Development
Table 67. Xinyu Pharmaceutical Company Information
Table 68. Xinyu Pharmaceutical Introduction and Business Overview
Table 69. Xinyu Pharmaceutical Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 70. Xinyu Pharmaceutical Neomycin Sulfate API Product Offerings
Table 71. Xinyu Pharmaceutical Recent Development
Table 72. Renfu Medicine Company Information
Table 73. Renfu Medicine Introduction and Business Overview
Table 74. Renfu Medicine Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Renfu Medicine Neomycin Sulfate API Product Offerings
Table 76. Renfu Medicine Recent Development
Table 77. Manus Aktteva Biopharma Company Information
Table 78. Manus Aktteva Biopharma Introduction and Business Overview
Table 79. Manus Aktteva Biopharma Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Manus Aktteva Biopharma Neomycin Sulfate API Product Offerings
Table 81. Manus Aktteva Biopharma Recent Development
Table 82. DKSH Company Information
Table 83. DKSH Introduction and Business Overview
Table 84. DKSH Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. DKSH Neomycin Sulfate API Product Offerings
Table 86. DKSH Recent Development
Table 87. Fagron Industry Company Information
Table 88. Fagron Industry Introduction and Business Overview
Table 89. Fagron Industry Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Fagron Industry Neomycin Sulfate API Product Offerings
Table 91. Fagron Industry Recent Development
Table 92. Caesar & Loretz GmbH Company Information
Table 93. Caesar & Loretz GmbH Introduction and Business Overview
Table 94. Caesar & Loretz GmbH Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Caesar & Loretz GmbH Neomycin Sulfate API Product Offerings
Table 96. Caesar & Loretz GmbH Recent Development
Table 97. Syndesmos Company Information
Table 98. Syndesmos Introduction and Business Overview
Table 99. Syndesmos Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Syndesmos Neomycin Sulfate API Product Offerings
Table 101. Syndesmos Recent Development
Table 102. B Joshi Agrochem Pharma Company Information
Table 103. B Joshi Agrochem Pharma Introduction and Business Overview
Table 104. B Joshi Agrochem Pharma Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. B Joshi Agrochem Pharma Neomycin Sulfate API Product Offerings
Table 106. B Joshi Agrochem Pharma Recent Development
Table 107. Crystal Pharma Company Information
Table 108. Crystal Pharma Introduction and Business Overview
Table 109. Crystal Pharma Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Crystal Pharma Neomycin Sulfate API Product Offerings
Table 111. Crystal Pharma Recent Development
Table 112. Sichuan Long March Pharmaceuticals Company Information
Table 113. Sichuan Long March Pharmaceuticals Introduction and Business Overview
Table 114. Sichuan Long March Pharmaceuticals Neomycin Sulfate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Sichuan Long March Pharmaceuticals Neomycin Sulfate API Product Offerings
Table 116. Sichuan Long March Pharmaceuticals Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Neomycin Sulfate API Downstream Customers
Table 120. Neomycin Sulfate API Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Neomycin Sulfate API Product Picture
Figure 2. Global Neomycin Sulfate API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Neomycin Sulfate API Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Neomycin Sulfate API Sales Volume (2020-2031) & (Tons)
Figure 5. Global Neomycin Sulfate API Sales Price (2020-2031) & (US$/Ton)
Figure 6. Neomycin Sulfate API Report Years Considered
Figure 7. Global Neomycin Sulfate API Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Neomycin Sulfate API Players Sales Volume Ranking (2024) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Neomycin Sulfate API Revenue in 2024
Figure 10. Neomycin Sulfate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Veterinary Use Picture
Figure 12. Human Use Picture
Figure 13. Global Neomycin Sulfate API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Neomycin Sulfate API Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Neomycin Sulfate API Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
Figure 16. Global Neomycin Sulfate API Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Neomycin Sulfate API Price by Type (2020-2031) & (US$/Ton)
Figure 18. Product Picture of Biopharmaceutical
Figure 19. Product Picture of Research
Figure 20. Global Neomycin Sulfate API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Neomycin Sulfate API Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Neomycin Sulfate API Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
Figure 23. Global Neomycin Sulfate API Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Neomycin Sulfate API Price by Application (2020-2031) & (US$/Ton)
Figure 25. North America Neomycin Sulfate API Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Neomycin Sulfate API Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Neomycin Sulfate API Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Neomycin Sulfate API Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Neomycin Sulfate API Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Neomycin Sulfate API Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Neomycin Sulfate API Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Neomycin Sulfate API Sales Volume (%), (2020-2031)
Figure 37. United States Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Neomycin Sulfate API Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Neomycin Sulfate API Sales Value by Application (%), 2024 VS 2031
Figure 43. China Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
Figure 45. China Neomycin Sulfate API Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Neomycin Sulfate API Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Neomycin Sulfate API Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Neomycin Sulfate API Sales Value by Application (%), 2024 VS 2031
Figure 55. India Neomycin Sulfate API Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Neomycin Sulfate API Sales Value by Type (%), 2024 VS 2031
Figure 57. India Neomycin Sulfate API Sales Value by Application (%), 2024 VS 2031
Figure 58. Neomycin Sulfate API Industrial Chain
Figure 59. Neomycin Sulfate API Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Neomycin Sulfate API market?
The top companies in the global Neomycin Sulfate API market are Yichang Three Gorges Pharmaceutical、Shandong Saito Biotechnology、Xinyu Pharmaceutical.
What was the global market size of Neomycin Sulfate API in 2025?
What was the global market size of Neomycin Sulfate API in 2031?
What is the annual compound growth rate of the global Neomycin Sulfate API market size from 2025 to 2031?
Which region is expected to have the highest market share?
Related Reports
Global Neomycin Sulfate API Market Research Report 2026
The global Neomycin Sulfate API market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 299 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 143
USD 2900.00
(Single User License)
Neomycin Sulfate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neomycin Sulfate API was estimated to be worth US$ 194 million in 2025 and is projected to reach US$ 299 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 116
USD 3950.00
(Single User License)
Global Neomycin Sulfate API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neomycin Sulfate API market is projected to grow from US$ 183 million in 2024 to US$ 283 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 168
USD 4900.00
(Single User License)
Global Neomycin Sulfate API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neomycin Sulfate API market size was US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 91
USD 4250.00
(Single User License)
Global Neomycin Sulfate API Market Research Report 2025
The global market for Neomycin Sulfate API was valued at US$ 183 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-02-14
Pages: 102
USD 2900.00
(Single User License)
Global Neomycin Sulfate API Market Insights, Forecast to 2030
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published Date: 2024-04-26
Pages: 113
USD 4900.00
(Single User License)
Global Neomycin Sulfate API Market Research Report 2024
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published Date: 2024-01-17
Pages: 97
USD 2900.00
(Single User License)
Global Neomycin Sulfate API Market Research Report 2026
The global Neomycin Sulfate API market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 299 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-02-02
Pages: 143
USD 2900.00 (Single User License)Neomycin Sulfate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neomycin Sulfate API was estimated to be worth US$ 194 million in 2025 and is projected to reach US$ 299 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-02-02
Pages: 116
USD 3950.00 (Single User License)Global Neomycin Sulfate API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neomycin Sulfate API market is projected to grow from US$ 183 million in 2024 to US$ 283 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 168
USD 4900.00 (Single User License)Global Neomycin Sulfate API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neomycin Sulfate API market size was US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 91
USD 4250.00 (Single User License)Global Neomycin Sulfate API Market Research Report 2025
The global market for Neomycin Sulfate API was valued at US$ 183 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-02-14
Pages: 102
USD 2900.00 (Single User License)Global Neomycin Sulfate API Market Insights, Forecast to 2030
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published: 2024-04-26
Pages: 113
USD 4900.00 (Single User License)Global Neomycin Sulfate API Market Research Report 2024
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published: 2024-01-17
Pages: 97
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now